Hashimoto Y, Mori S, Hama N, Nakao K, Imura H, Yamaguchi M, Yasuhara M, Hori R
Department of Pharmacy, Kyoto University Hospital, Japan.
J Pharmacokinet Biopharm. 1993 Jun;21(3):281-97. doi: 10.1007/BF01059780.
Natriuretic peptides have not only natriuretic/diuretic but also hypotensive activities, and the decreased renal perfusion caused by the excessive hypotension is known to attenuate the diuretic actions. The present study was designed to examine the relationship between the dosing (intravenous constant infusion) rates and the diuretic actions of alpha-rat atrial natriuretic peptide (alpha-rANP) and rat brain natriuretic peptide (rBNP) in rats, and population (nonlinear mixed effect model) analysis was applied to these complicated diuretic actions. The intrinsic diuretic activities of alpha-rANP and rBNP could be analyzed, and the effects of blood pressure, heart rate, and also inhibition of degradation enzyme on the diuresis of natriuretic peptides were estimated simultaneously. The population analysis was useful for analyzing such pharmacodynamic data for which the individual analysis could not be applied easily.
利钠肽不仅有利钠/利尿作用,还有降压作用,而且已知过度低血压引起的肾灌注减少会减弱利尿作用。本研究旨在探讨大鼠中α-大鼠心房利钠肽(α-rANP)和大鼠脑利钠肽(rBNP)的给药(静脉恒速输注)速率与利尿作用之间的关系,并将群体(非线性混合效应模型)分析应用于这些复杂的利尿作用。可以分析α-rANP和rBNP的内在利尿活性,并同时评估血压、心率以及降解酶抑制对利钠肽利尿作用的影响。群体分析对于分析难以进行个体分析的此类药效学数据很有用。